E11.3559 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

Name of the Condition

• Common Name: Type 2 Diabetes with Stable Proliferative Diabetic Retinopathy, Unspecified Eye
• Medical Term: Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina of an unspecified eye, with no active progression or worsening of retinal changes. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The "stable" designation indicates that the proliferative changes are not actively advancing, though ongoing monitoring is essential.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure. In the stable phase, the abnormal vessels are present but not actively proliferating or causing new complications.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Often asymptomatic in early stages.
• Blurred or distorted vision.
• Floaters or dark spots in the visual field.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging and optical coherence tomography (OCT), to assess retinal blood vessel changes. Fluorescein angiography may be used to identify abnormal vessel growth. Blood glucose and HbA1c tests confirm underlying diabetes. The "stable" classification requires documentation of no recent progression of retinal changes over time.

Treatment Options

Treatment focuses on managing blood sugar levels to prevent further retinal damage. Laser photocoagulation or anti-VEGF injections may be used to reduce abnormal vessel growth. Regular eye exams are critical to monitor for progression. Blood pressure and cholesterol management are also important adjunctive measures.

Prognosis and Follow-Up

With proper management, vision loss can be slowed or prevented. However, the condition requires lifelong monitoring, as stability can change. Follow-up visits typically occur every 3–6 months, with more frequent checks if changes occur. Early intervention improves outcomes.

Complications

Untreated or unstable proliferative retinopathy can lead to retinal detachment, vitreous hemorrhage, or glaucoma, resulting in permanent vision loss. Even in stable cases, the risk of progression remains if diabetes is poorly controlled.

Lifestyle & Prevention

• Maintain tight blood glucose control through diet, exercise, and medication.
• Regular eye screenings to detect changes early.
• Manage blood pressure and cholesterol.
• Avoid smoking and limit alcohol intake.
• Adopt a heart-healthy diet rich in fruits, vegetables, and whole grains.

When to Seek Professional Help

Seek immediate care if you experience sudden vision loss, floaters, or flashes of light, as these may indicate retinal detachment or hemorrhage. Routine follow-ups are essential even if symptoms are absent.

Tips for Medical Coders

Document the eye laterality as "unspecified" when the specific eye is not documented. Ensure "stable" is clearly indicated to differentiate from active proliferative retinopathy. Code E11.3559 is appropriate when the eye is not specified and the condition is stable. Verify that diabetes type (type 2) and retinopathy stage are accurately reflected in the record.